 |
blinatumomab |
|---|---|
| Trade Name | |
| Orphan Indication | Prolymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2008-05-16 00:00:00 |
| Sponsor | Amgen, Inc.;One Amgen Center Drive;Thousand Oaks, California |
| |
blinatumomab |
|---|---|
| Trade Name | |
| Orphan Indication | Prolymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2008-05-16 00:00:00 |
| Sponsor | Amgen, Inc.;One Amgen Center Drive;Thousand Oaks, California |